Table 2.
Patient characteristics and PET parameters in primary tumor.
| Patient | Sex | TNM | Histology | [18F]D4-FCH Dynamic Scan | [18F]D4-FCH Static Scan | [18F]FDG Static Scan | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUV 5 min | SUV 30 min | SUV 60 min | SUV 60 min | SUV 60 min | |||||||||
| mean | max | mean | max | mean | max | mean | max | mean | max | ||||
| 1 | F | T4N0M1c | Adenocarcinoma | 4.51 | 7.88 | 4.76 | 8.42 | 4.77 | 8.46 | 4.73 | 8.64 | No FDG | |
| 2 | F | T4N2M1b | Squamous | 3.58 | 8.57 | 4.23 | 9.10 | 4.28 | 9.51 | 6.06 | 10.13 | No FDG | |
| 3 | M | T2aN0M0 | Squamous | 2.28 | 2.65 | 2.64 | 3.01 | 2.80 | 3.17 | 2.95 | 6.14 | 7.46 | 11.95 |
| 4 | F | T1bN1M0 | Squamous | 2.96 | 4.32 | 3.11 | 4.29 | 3.20 | 4.53 | 3.46 | 5.41 | 7.10 | 10.77 |
| 5 | M | T4N1M0 | Squamous | 5.36 | 7.98 | 5.26 | 7.43 | 5.29 | 7.79 | 5.47 | 9.15 | 8.02 | 14.10 |
| 6 | M | T2bN0M1b | Squamous | 3.68 | 7.46 | 3.20 | 6.14 | 3.18 | 6.09 | 3.12 | 3.20 | 9.55 | 12.2 |
| 7 | F | T1bN1M0 | Squamous | 2.85 | 5.32 | 2.59 | 3.87 | 2.54 | 3.83 | 2.24 | 3.18 | 4.96 | 6.89 |
| 8 | F | T3N2M0 | Adenocarcinoma | 2.85 | 5.32 | 2.59 | 3.87 | 2.54 | 3.83 | No FDG | |||
| 9 | M | T1bN0M0 | Adenocarcinoma | 3.34 | 4.76 | 3.34 | 5.03 | 3.39 | 5.15 | 2.79 | 3.68 | 5.43 | 7.36 |
| 10 | M | T4N3M1a | Adenocarcinoma | 3.53 | 6.70 | 2.51 | 5.05 | 2.13 | 4.68 | 3.00 | 3.80 | No FDG | |
| 11 | M | T3N1M0 | Squamous | 3.86 | 5.11 | 4.06 | 5.69 | 4.24 | 6.19 | 3.65 | 4.84 | 5.11 | 6.94 |
| 4.23 | 7.04 | 4.68 | 7.43 | 4.84 | 8.15 | 4.82 | 6.99 | 11.93 | 22.64 | ||||
| 12 | F | T3N2M1b | Adenocarcinoma | 2.61 | 2.61 | 2.23 | 2.23 | 2.08 | 2.08 | 1.94 | 2.87 | 3.70 | 5.63 |
| 13 | F | T3N1M1b | Adenocarcinoma | 4.18 | 4.62 | 3.54 | 4.17 | 3.23 | 4.57 | 2.77 | 4.45 | 5.53 | 10.01 |
| 14 | F | T4N2M1a | Squamous | 3.09 | 4.64 | 2.80 | 4.03 | 2.65 | 3.97 | 2.87 | 3.48 | 7.29 | 12.82 |
| 15 | M | T3N2M1b | Squamous | 2.41 | 5.38 | 3.28 | 6.33 | 3.41 | 6.39 | 3.54 | 7.59 | 4.11 | 7.58 |
| 16 | M | T4N2M0 | Adenocarcinoma | 2.61 | 5.83 | 2.90 | 5.22 | 2.96 | 6.16 | 2.60 | 3.84 | 7.06 | 12.28 |
| 17 | F | T3N2M1b | Adenocarcinoma | 4.37 | 8.13 | 4.34 | 6.94 | 4.37 | 7.01 | No FDG | |||
M, Male; F, Female